Handelsbanken Fonder AB Acquires 3,000 Shares of Confluent, Inc. $CFLT

Handelsbanken Fonder AB increased its holdings in shares of Confluent, Inc. (NASDAQ:CFLT) by 5.0% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 62,792 shares of the company’s stock after purchasing an additional 3,000 shares during the quarter. Handelsbanken Fonder AB’s holdings in Confluent were worth $1,565,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its holdings in Confluent by 7.2% during the 1st quarter. Vanguard Group Inc. now owns 26,620,150 shares of the company’s stock valued at $623,976,000 after buying an additional 1,791,588 shares in the last quarter. Altimeter Capital Management LP boosted its position in shares of Confluent by 11.0% during the first quarter. Altimeter Capital Management LP now owns 13,042,080 shares of the company’s stock worth $305,706,000 after acquiring an additional 1,295,710 shares during the last quarter. Champlain Investment Partners LLC boosted its position in shares of Confluent by 0.3% during the first quarter. Champlain Investment Partners LLC now owns 10,862,083 shares of the company’s stock worth $254,607,000 after acquiring an additional 27,329 shares during the last quarter. William Blair Investment Management LLC grew its stake in Confluent by 3.8% during the second quarter. William Blair Investment Management LLC now owns 9,639,102 shares of the company’s stock valued at $240,303,000 after acquiring an additional 356,277 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD increased its holdings in Confluent by 13.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 5,510,743 shares of the company’s stock valued at $129,173,000 after acquiring an additional 654,827 shares during the last quarter. 78.09% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have commented on CFLT shares. Evercore ISI increased their price objective on shares of Confluent from $23.00 to $28.00 and gave the company an “outperform” rating in a report on Tuesday, October 28th. Wells Fargo & Company increased their price target on Confluent from $24.00 to $30.00 and gave the company an “overweight” rating in a research note on Tuesday, October 28th. Raymond James Financial reaffirmed an “outperform” rating and issued a $30.00 price objective (up previously from $25.00) on shares of Confluent in a research note on Tuesday, October 28th. Stifel Nicolaus upped their price objective on Confluent from $21.00 to $25.00 and gave the stock a “hold” rating in a report on Tuesday, October 28th. Finally, Zacks Research upgraded Confluent from a “strong sell” rating to a “hold” rating in a research report on Monday, September 1st. One investment analyst has rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating, ten have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $27.97.

Insider Transactions at Confluent

In related news, CRO Ban Ryan Norris Mac sold 15,062 shares of Confluent stock in a transaction dated Thursday, November 20th. The shares were sold at an average price of $22.51, for a total transaction of $339,045.62. Following the completion of the transaction, the executive directly owned 381,064 shares of the company’s stock, valued at approximately $8,577,750.64. The trade was a 3.80% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Rohan Sivaram sold 25,858 shares of the company’s stock in a transaction dated Thursday, November 20th. The shares were sold at an average price of $22.51, for a total transaction of $582,063.58. Following the transaction, the chief financial officer owned 599,738 shares in the company, valued at $13,500,102.38. The trade was a 4.13% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 808,186 shares of company stock worth $17,197,298. 9.20% of the stock is currently owned by insiders.

Confluent Price Performance

Shares of Confluent stock opened at $21.83 on Thursday. The stock has a market cap of $7.64 billion, a price-to-earnings ratio of -24.26 and a beta of 0.98. The company has a debt-to-equity ratio of 0.98, a quick ratio of 4.01 and a current ratio of 4.01. The stock has a 50 day moving average price of $22.04 and a 200-day moving average price of $22.01. Confluent, Inc. has a one year low of $15.64 and a one year high of $37.90.

Confluent (NASDAQ:CFLT) last issued its quarterly earnings results on Monday, October 27th. The company reported $0.13 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.10 by $0.03. The company had revenue of $298.52 million during the quarter, compared to the consensus estimate of $292.69 million. Confluent had a negative return on equity of 25.40% and a negative net margin of 27.32%.Confluent’s revenue was up 19.3% on a year-over-year basis. During the same period last year, the company earned $0.10 earnings per share. Confluent has set its Q4 2025 guidance at 0.090-0.100 EPS. FY 2025 guidance at 0.390-0.400 EPS. Equities analysts expect that Confluent, Inc. will post -0.83 EPS for the current year.

Confluent Company Profile

Confluent, Inc operates a data streaming platform in the United States and internationally. The company provides platforms that allow customers to connect their applications, systems, and data layers, such as Confluent Cloud, a managed cloud-native software-as-a-service; and Confluent Platform, an enterprise-grade self-managed software.